Edward T.Kennedy (Ed)

Ed Kennedy, who co-leads the Firm's global Tax Practice, works with Fortune 500 companies, strategic investors, private equity groups, and hedge funds to structure their investments in a tax-efficient manner. He also works with large U.S.-based multinational corporations in connection with their global tax planning. Ed works with foreign entities and foreign sovereign wealth funds in connection with their inbound investments in the U.S., including investments in stock, securities, partnerships, and real estate. His practice involves all aspects of federal and international taxation, including M&A, Subpart F planning, contract manufacturing, hedging programs, cross-border structured finance, partnership planning, tax controversy, and cost sharing.

Ed worked on the federal and international tax aspects of the restructuring of Chrysler LLC in chapter 11. He worked with Reynolds American in connection with its acquisition by British American Tobacco Plc in a deal valued at $49 billion. He advised Monster Beverage Corporation in connection with its long-term commercial relationship with The Coca Cola Company, with Monster Beverage Corporation receiving a net cash payment of $2.15 billion. He represented Gtech S.p.A. in connection with its acquisition of International Game Technology for $6.4 billion. Ed also played a leading role in structuring Pfizer's $16.6 billion sale of its consumer health care business to Johnson & Johnson.

Ed, a member of the New York State Bar Association Tax Section, has lectured at conferences on numerous topics involving federal and international taxation.